Maria Letizia Barreca
机构: Department of Pharmaceutical Sciences - University of Perugia
每年引用次数
引用次数
引用: 4,986
H-指数: 41
I10-指数 : 89
出版物: 243
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS
N. Iraci , Alba Chimirri , Sara De Grazia , Ferro Stefania
2008
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS
N. Iraci , Alba Chimirri , Ferro Stefania , DE Luca Laura
2008
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones
Rosaria Gitto , Maria L. Barreca , Eleonora Francica , Roberta Caruso
Arkivoc 2004 ( 5)
10
2004
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors
Andrea Astolfi , Tommaso Felicetti , Nunzio Iraci , Giuseppe Manfroni
Journal of Medicinal Chemistry 60 ( 4) 1598 -1604
21
2017
New Insights on KCa3.1 Channel Modulation
Giuseppe Manfroni , Francesco Ragonese , Lorenzo Monarca , Andrea Astolfi
Current Pharmaceutical Design 26 ( 18) 2096 -2101
1
2020
Molecular Dynamics Studies of the Wild-Type and Double Mutant HIV-1 Integrase Complexed with the 5CITEP Inhibitor: Mechanism for Inhibition and Drug Resistance
Maria L. Barreca , Keun Woo Lee , Alba Chimirri , James M. Briggs
Biophysical Journal 84 ( 3) 1450 -1463
65
2003
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
Maria L. Barreca , Jan Balzarini , Alba Chimirri , Erik De Clercq
Journal of Medicinal Chemistry 45 ( 24) 5410 -5413
138
2002
Papain catalyzed hydrolysis of aryl esters: a comparison of the hansch, docking and CoMFA methods
A. Carotti , A. Carrieri , C. Altomare , M. L. Barreca
Farmaco 49 ( 9) 573 -585
12
1994
Search for noncompetitive 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies
A. Chimirri , G. De Sarro , S. Quartarone , M. L. Barreca
Pure and Applied Chemistry 76 ( 5) 931 -939
6
2004
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives.
G. Franci , G. Manfroni , R. Cannalire , T. Felicetti
Cell Proliferation 48 ( 6) 705 -717
5
2015
Induced‐Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV‐1 Integrase Inhibitors
Maria Letizia Barreca , Nunzio Iraci , Laura De Luca , Alba Chimirri
ChemMedChem 4 ( 9) 1446 -1456
48
2009
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non–Nucleoside riverse Transcriptase Inhibitors
Laura DE LUCA , Ml Barreca , Nunzio Iraci , Stefania Ferro
2007
Studi Computazionali per l'Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell'HIV-1
Nunzio Iraci , Laura DE LUCA , Ml Barreca , A Rao
P44 -P44
2006
Design and synthesis of new 2, 3-diaryl-1, 3-thiazolidin-4-one HIV-1 RT-inhibitors.
M Zappalà , J Balzarini , Ml Barreca , A Carbone
2002
Progettazione di nuovi agenti anti-HIV e individuazione di nuovi lead compound.
Ml Barreca , A Carbone , Alba Chimirri , E De Clercq
2002
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors
Stefania Ferro , Stefano Agnello , Laura DE LUCA , Ml Barreca
192 -192
2009
Pharmacophore Modeling, Docking Experiments And Discovery Of New Hiv-1 NNRTIs.
Laura DE LUCA , Ml Barreca , A Rao , Anna Maria Monforte
ITA 154 -154
2006
Targeting protein-protein interactions: a promising anti-HIV drug discovery strategy
Laura DE LUCA , Stefania Ferro , Rosaria Gitto , Ml Barreca
56 -56
2011
Discovery of potent HIV-1 integrase strand transfer inhibitors: design and synthetic strategies
Sara DE GRAZIA , Stefania Ferro , Laura DE LUCA , Ml Barreca
P41 -P41
2009
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors
Stefania Ferro , Laura DE LUCA , Sara DE GRAZIA , Rosaria Gitto
ITA P22 -P22
2009